Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Effector Therapeutics To Collaborate With Stanford Medicine On Phase 2 Study In Patients With Breast Cancer

April 11 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS TO COLLABORATE WITH STANFORD
MEDICINE ON
INVESTIGATOR-INITIATED RANDOMIZED PHASE 2 STUDY IN PATIENTS WITH
ER+ BREAST CANCER

Source text for Eikon:  ID:nGNX28BrLq 
Further company coverage:  EFTR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news